These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. [New drug approvals: Ripretinib for advanced gastrointestinal stromal tumors (GIST) in fourth or later-line therapy]. Lemaître J; Watson S Bull Cancer; 2022 Mar; 109(3):250-252. PubMed ID: 35094842 [No Abstract] [Full Text] [Related]
11. Gastrointestinal stromal tumors - Summary of mutational status of the primary/secondary KIT/PDGFRA mutations, BRAF mutations and SDH defects. Kalfusova A; Linke Z; Kalinova M; Krskova L; Hilska I; Szabova J; Vicha A; Kodet R Pathol Res Pract; 2019 Dec; 215(12):152708. PubMed ID: 31708372 [TBL] [Abstract][Full Text] [Related]
12. Management of Gastrointestinal Stromal Tumour: Current Practices and Visions for the Future. Blay JY; Casali PG; Dei Tos AP; Le Cesne A; Reichardt P Oncology; 2015; 89(1):1-13. PubMed ID: 25720422 [TBL] [Abstract][Full Text] [Related]
13. Proteogenomics for the Study of Gastrointestinal Stromal Tumors. Kondo T Adv Exp Med Biol; 2016; 926():139-151. PubMed ID: 27686810 [TBL] [Abstract][Full Text] [Related]
14. Identifying Secondary Mutations in Chinese Patients with Imatinib-Resistant Gastrointestinal Stromal Tumors (GISTs) by Next Generation Sequencing (NGS). Du J; Wang S; Wang R; Wang SY; Han Q; Xu HT; Yang P; Liu Y Pathol Oncol Res; 2020 Jan; 26(1):91-100. PubMed ID: 31758409 [TBL] [Abstract][Full Text] [Related]
16. Ripretinib in advanced gastrointestinal stromal tumors: an overview of current evidence and drug approval. Goggin C; Stansfeld A; Mahalingam P; Thway K; Smith MJ; Huang P; Jones RL; Napolitano A Future Oncol; 2022 Aug; 18(26):2967-2978. PubMed ID: 35880452 [TBL] [Abstract][Full Text] [Related]
17. [The importance of mutational status in prognosis and therapy of GIST]. Comandone A; Boglione A Recenti Prog Med; 2015 Jan; 106(1):17-22. PubMed ID: 25621775 [TBL] [Abstract][Full Text] [Related]
18. [Advanced GIST: Which treatments in 2022?]. Mas L; Bachet JB Bull Cancer; 2022 Oct; 109(10):1082-1087. PubMed ID: 35934543 [TBL] [Abstract][Full Text] [Related]
19. Duodenal gastrointestinal stromal tumor: From clinicopathological features to surgical outcomes. Marano L; Boccardi V; Marrelli D; Roviello F Eur J Surg Oncol; 2015 Jul; 41(7):814-22. PubMed ID: 25956211 [TBL] [Abstract][Full Text] [Related]
20. Gastrointestinal stromal tumors with KIT exon 9 mutations: Update on genotype-phenotype correlation and validation of a high-resolution melting assay for mutational testing. Künstlinger H; Huss S; Merkelbach-Bruse S; Binot E; Kleine MA; Loeser H; Mittler J; Hartmann W; Hohenberger P; Reichardt P; Büttner R; Wardelmann E; Schildhaus HU Am J Surg Pathol; 2013 Nov; 37(11):1648-59. PubMed ID: 24061512 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]